Publicaciones (74) Publicaciones de Miguel Cervero Jiménez

2024

  1. Corrigendum to: “Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D” [Biomed. Pharmacother. 150 (2022) 1−11] (Biomedicine & Pharmacotherapy (2022) 150, (S0753332222003547), (10.1016/j.biopha.2022.112965))

    Biomedicine and Pharmacotherapy

  2. Dasatinib interferes with HIV-1 proviral integration and the inflammatory potential of monocyte-derived macrophages from people with HIV

    Biochemical Pharmacology, Vol. 229

  3. Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe

    Pediatric Infectious Disease Journal, Vol. 43, Núm. 5, pp. E155-E159

  4. Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile

    Open Forum Infectious Diseases, Vol. 11, Núm. 4

  5. Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus

    Frontiers in Immunology, Vol. 15

  6. Prospective study for the early detection of lung carcinoma in patients with HIV infection (GESIDA study 8815)

    Enfermedades Infecciosas y Microbiologia Clinica

2023

  1. HIV medical care interruption among people living with HIV in Spain, 2004-2020

    AIDS, Vol. 37, Núm. 8, pp. 1277-1284

  2. Patterns of Sexualized Drug Use among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV: Insights from a Comprehensive Study—The U-SEX-2 GESIDA 9416 Study

    Journal of Clinical Medicine, Vol. 12, Núm. 23

2022

  1. Amikacin pharmacokinetics in elderly patients with severe infections

    European Journal of Pharmaceutical Sciences, Vol. 175

  2. Association of Latin-American Ethnicity with an Increase in Weight in an HIV-Infected Outpatient Population

    Infectious Diseases and Therapeutics, Vol. 3, Núm. 1

  3. Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D3 in Hospitalized Patients With COVID-19: A Multicenter, Single-Blinded, Prospective Randomized Pilot Clinical Trial

    Frontiers in Pharmacology, Vol. 13

  4. Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D

    Biomedicine & Pharmacotherapy, Vol. 150, pp. 112965

  5. Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, Vol. 150, pp. 112965

  6. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  7. Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study

    Medicine (United States), Vol. 101, Núm. 24, pp. E29252

  8. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

  9. Reply: «Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure»

    Medicina Clinica

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

  3. Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU

    Frontiers in Immunology, Vol. 12